| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/29/2005 | EP1546414A2 Hcv assay |
| 06/29/2005 | EP1546411A2 Method for diagnosing prostate cancer |
| 06/29/2005 | EP1546409A2 Method for diagnosing chronic myeloid leukemia |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546362A1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 06/29/2005 | EP1546361A1 Auto-stimulating cells and method for making and using the same |
| 06/29/2005 | EP1546357A2 Immunogenic mycoplasma hyopneumoniae polypeptides |
| 06/29/2005 | EP1546343A2 High titer recombinant aav production |
| 06/29/2005 | EP1546342A2 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 06/29/2005 | EP1546338A1 Polynucleotides and polypeptides derived from lactobacillus rhamnosus hn001 |
| 06/29/2005 | EP1546336A2 Polynucleotides and polypeptides in plants |
| 06/29/2005 | EP1546333A1 Aspartyl protease inhibitor as a nematode allergen |
| 06/29/2005 | EP1546332A1 Nuclear receptor transcriptional corepressor and uses thereof |
| 06/29/2005 | EP1546331A2 Integrase cofactor |
| 06/29/2005 | EP1546326A2 Novel compositions and methods for the treatment of psoriasis |
| 06/29/2005 | EP1546324A1 Expression vectors encoding epitopes of target-associated antigens |
| 06/29/2005 | EP1546323A2 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 06/29/2005 | EP1546313A1 Thermostable rna ligase from thermus phage |
| 06/29/2005 | EP1546312A2 Glucose transport mutants for production of biomaterial |
| 06/29/2005 | EP1546235A2 Water-soluble polymer alkanals |
| 06/29/2005 | EP1546206A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 06/29/2005 | EP1546202A1 Human coagulation factor vii polypeptides |
| 06/29/2005 | EP1546201A2 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3. |
| 06/29/2005 | EP1546200A2 Stabilized exendin-4 compounds |
| 06/29/2005 | EP1546199A2 Novel chemokine-like polypeptides |
| 06/29/2005 | EP1546198A1 Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
| 06/29/2005 | EP1546197A2 Genes and polypeptides relating to prostate cancers |
| 06/29/2005 | EP1546195A1 Improved mutants of biotin binding protein |
| 06/29/2005 | EP1546194A2 Therapeutic uspa1-derived peptides |
| 06/29/2005 | EP1546193A1 Pegylated t1249 polypeptide |
| 06/29/2005 | EP1546192A1 Orthopoxvirus vectors, genes and products thereof |
| 06/29/2005 | EP1546191A2 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 06/29/2005 | EP1546190A2 Hbv mutations associated with reduced susceptibility to adefovir |
| 06/29/2005 | EP1546189A2 Novel compositions and methods for the treatment of immune-related diseases |
| 06/29/2005 | EP1546188A2 P53 binding t cell receptor molecules and uses thereof |
| 06/29/2005 | EP1546187A2 Purification process comprising microfiltration at elevated temperatures |
| 06/29/2005 | EP1546185A1 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| 06/29/2005 | EP1546184A2 Human immunosuppressive protein |
| 06/29/2005 | EP1546183A2 Isolation and use of ryanodine receptors |
| 06/29/2005 | EP1546182A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/29/2005 | EP1546178A2 Adenoviral va1 pol iii expression system for rna expression |
| 06/29/2005 | EP1546176A2 Methods and compositions concerning altered yellow fever virus strains |
| 06/29/2005 | EP1546171A1 Gene families associated with stomach cancer |
| 06/29/2005 | EP1546090A2 Method for producing acylated peptides |
| 06/29/2005 | EP1545638A1 Controlled release therapeutic wound dressings |
| 06/29/2005 | EP1545628A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 06/29/2005 | EP1545627A2 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 06/29/2005 | EP1545625A2 Flexible vaccine assembly and vaccine delivery platform |
| 06/29/2005 | EP1545617A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 06/29/2005 | EP1545616A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 06/29/2005 | EP1545610A2 Epitope sequences |
| 06/29/2005 | EP1545609A2 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 06/29/2005 | EP1545607A1 Allergy vaccines |
| 06/29/2005 | EP1545603A2 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 06/29/2005 | EP1545602A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2005 | EP1545600A2 Protein and peptide expression for passive immunity |
| 06/29/2005 | EP1545595A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/29/2005 | EP1545594A1 Bacteriophage-mediated immunisation against hepatitis |
| 06/29/2005 | EP1545587A1 Lactoferrin compositions and methods of wound treatment |
| 06/29/2005 | EP1545584A2 Method for reducing morbidity and mortality in critically ill patients |
| 06/29/2005 | EP1545581A1 Peptides and related molecules that modulate nerve growth factor activity |
| 06/29/2005 | EP1545580A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 06/29/2005 | EP1545577A2 Igf-binding protein-derived peptide or small molecule |
| 06/29/2005 | EP1545576A2 Methods of using non-human animal apoliprotein a-i protein |
| 06/29/2005 | EP1545575A2 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
| 06/29/2005 | EP1545557A2 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 06/29/2005 | EP1545556A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 06/29/2005 | EP1545460A2 Insulin molecule having protracted time action |
| 06/29/2005 | EP1545428A2 Process for decreasing aggregate levels of pegylated protein |
| 06/29/2005 | EP1495142A4 "doping" in walk-through mutagenesis |
| 06/29/2005 | EP1474161A4 Engineered binding proteins |
| 06/29/2005 | EP1423538A4 Methods of using 5433, a human calcium channel family member |
| 06/29/2005 | EP1272507B1 Integrin binding peptide derivatives |
| 06/29/2005 | EP1173619B1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 06/29/2005 | EP1141012B1 Modification of interferon alpha production |
| 06/29/2005 | EP1121425B1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 06/29/2005 | EP1119625B1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/29/2005 | EP1037990B8 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/29/2005 | EP1025216B1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 06/29/2005 | EP1015037B1 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES |
| 06/29/2005 | EP1012255B1 Enhancement of growth in plants |
| 06/29/2005 | EP0954326B1 A process for viral inactivation of lyophilized blood proteins |
| 06/29/2005 | EP0929574B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
| 06/29/2005 | EP0886678B1 Export systems for recombinant proteins |
| 06/29/2005 | EP0864645B1 Negative-strand rna virus vector having autonomously replicating activity |
| 06/29/2005 | EP0773957B1 Secreted hepatitis C virus E1/E2 complex obtained from C-terminally truncated E1 and E2 polypeptides |
| 06/29/2005 | EP0748386B1 Production of fibrinogen in transgenic animals |
| 06/29/2005 | EP0721501B1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 06/29/2005 | EP0693125B1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin |
| 06/29/2005 | CN1633598A Toll-like receptor 3 signaling agonists and antagonists |
| 06/29/2005 | CN1633499A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633447A N-formyl peptide receptor complex with a G-protein kinase signal pathway modification agent |
| 06/29/2005 | CN1632123A Sand sagebrush AdZFP1 transcription factor gene and its use in cultivation of drought enduring plant |
| 06/29/2005 | CN1632121A Wheat small GTP binding protein Rab2 gene TaRab2 and its use |
| 06/29/2005 | CN1632120A Hepcidin antibiotic peptide gene of weever cultured in sea water |
| 06/29/2005 | CN1632119A Human LSB gene sequence, encoded polypeptide thereof, preparation method and use therefor |
| 06/29/2005 | CN1632116A Enhancement of virus-mediated DNA transfer |
| 06/29/2005 | CN1631900A Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component |
| 06/29/2005 | CN1631899A Use of DLP in Pre-mRNA splicing and cell cycle control |